Deltex Medical Group (DEMG.L)
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers oesophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; TrueVue Loops that plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.
Company Info
ISIN | GB0059337583 |
---|---|
Sector | Healthcare |
Industry | Medical Devices |
Highlights
Market Cap | £2.18M |
---|---|
PE Ratio | 10.27 |
Revenue (TTM) | £1.78M |
Gross Profit (TTM) | £1.84M |
EBITDA (TTM) | -£625.00K |
Year Range | £0.09 - £1.45 |
Target Price | £8.00 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Deltex Medical Group, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Deltex Medical Group had a return of -20.69% year-to-date (YTD) and -92.07% in the last 12 months. Over the past 10 years, Deltex Medical Group had an annualized return of -38.31%, while the S&P 500 had an annualized return of 10.99%, indicating that Deltex Medical Group did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -20.69% | 11.18% |
1 month | -8.00% | 5.60% |
6 months | -23.33% | 17.48% |
1 year | -92.07% | 26.33% |
5 years (annualized) | -40.17% | 13.16% |
10 years (annualized) | -38.31% | 10.99% |
Monthly Returns
The table below presents the monthly returns of DEMG.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 3.45% | -23.33% | -6.52% | 16.28% | -20.69% | ||||||||
2023 | 25.00% | -8.00% | 0.00% | 26.09% | -10.34% | -7.69% | -84.17% | -7.89% | -11.43% | 0.00% | -6.45% | -85.50% | |
2022 | -3.51% | -9.09% | -0.00% | 2.00% | -3.92% | -6.12% | -8.70% | 0.00% | -11.90% | -2.70% | 0.00% | 11.11% | -29.82% |
2021 | 28.57% | 11.11% | -15.00% | 8.82% | -8.11% | 0.00% | -0.00% | 2.94% | -11.43% | 0.00% | -1.61% | -6.56% | 1.79% |
2020 | -1.79% | -12.73% | 4.17% | 68.00% | -19.05% | -11.76% | -6.67% | 1.79% | -3.51% | -9.09% | 6.00% | 5.66% | -0.00% |
2019 | 27.78% | 39.13% | -25.00% | 14.58% | 23.64% | -14.71% | 8.62% | -11.11% | -5.36% | -11.32% | -4.26% | 24.44% | 55.56% |
2018 | -37.65% | 1.89% | -1.85% | 5.66% | -7.14% | -19.23% | -19.05% | 17.65% | 30.00% | -5.77% | -6.12% | -21.74% | -57.65% |
2017 | 3.23% | 0.00% | -6.25% | 6.67% | 0.00% | -3.12% | -6.45% | -20.69% | -0.00% | -8.70% | -9.52% | -10.53% | -45.16% |
2016 | 14.71% | -15.18% | -6.06% | -0.00% | 12.90% | 8.57% | 10.53% | 7.14% | -11.11% | -17.50% | 0.00% | -6.06% | -8.61% |
2015 | -21.05% | -3.33% | 20.69% | 40.00% | 8.16% | -7.55% | -4.08% | -4.26% | -17.78% | -0.00% | -5.41% | -2.86% | -10.53% |
2014 | -3.60% | 9.35% | -17.09% | -5.15% | -2.99% | 0.00% | -13.48% | -3.90% | -5.41% | -11.43% | -12.90% | -29.63% | -65.67% |
2013 | -15.80% | -9.03% | -17.36% | -3.19% | -1.91% | 20.35% | -16.91% | 16.81% | 6.82% | -5.67% | -10.53% | -6.72% | -40.96% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of DEMG.L is 6, indicating that it is in the bottom 6% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
DEMG.L (Deltex Medical Group)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Deltex Medical Group (DEMG.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Deltex Medical Group. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Deltex Medical Group was 99.69%, occurring on Mar 26, 2024. The portfolio has not yet recovered.
The current Deltex Medical Group drawdown is 99.65%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.69% | Oct 26, 2004 | 4833 | Mar 26, 2024 | — | — | — |
-87.1% | Nov 15, 2001 | 155 | Oct 17, 2002 | 216 | Jan 20, 2004 | 371 |
-30.73% | Jan 21, 2004 | 45 | Mar 23, 2004 | 149 | Oct 25, 2004 | 194 |
-5% | Nov 9, 2001 | 1 | Nov 9, 2001 | 2 | Nov 13, 2001 | 3 |
Volatility
Volatility Chart
The current Deltex Medical Group volatility is 11.24%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |